Oxti.com
Title
Oxxon Therapeutics
Description
Oxxon Therapeutics™ (Oxxon) is a therapeutic vaccines company developing the next generation of innovative immunotherapies to treat patients with chronic infectious diseases and cancer. To date, the company has built an initial pipeline through its patented Hi-8™ PrimeBoost™ immunotherapy platform, an approach that allows the rapid development of products to selectively stimulate and enhance potent immune responses. The company currently has three development programs in hepatitis, melanoma and HIV, two of which are in Phase II clinical trials. In addition, the company is leveraging its enabling platform through partnerships with companies developing therapeutic and preventative vaccine products.
Logos
Additional Information
Related Domains
Categories:
- Antigen
- Biopharmaceutical
- Biopharmaceuticals
- Biotech
- Biotechnology
- Biotechnology And Pharmaceuticals
- Business
- Cancer
- England
- Europe
- Hiv
- Hepatitis
- Immune Response
- Immune System
- Immunotherapies
- Infectious Disease
- Melanoma
- Oxford
- Oxfordshire
- Oxxon Therapeutics
- Pharmaceuticals
- Phase Ii Clinical Trials
- Pox Virus Vector
- T Cells
- United Kingdom
- Vaccine
- Vaccines
- Vector
- Biotechnology and Pharmaceuticals
- Business and Economy
- HIV
- Phase II Clinical Trials
- Regional